신장 보존 시장 규모, 점유율 및 동향 분석 보고서 : 보존액별, 방법별, 도너 유형별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Kidney Preservation Market Summary

The global kidney preservation market size was valued at USD 66.6 million in 2025 and is projected to grow from USD 71.3 million in 2026 to USD 114.9 million by 2033, at a CAGR of 7.1% from 2026 to 2033. North America held the largest share of 37.3% of the global market in 2025. The growth is driven by multiple factors, including the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), rising demand for organ transplantation, and advancements in preservation technologies.

The growing number of patients awaiting kidney transplants is fueling the demand for effective preservation solutions. The aging global population further contributes to this demand, as kidney disease incidence rises with age, leading to a larger pool of potential transplant recipients. According to the World Health Organization (WHO), the global geriatric population is expected to increase from 1.2 billion in 2025 to around 2.1 billion in 2050. The growing awareness about kidney donation and transplantation is significantly influencing the kidney transplant organ preservation by expanding the donor pool and increasing transplant procedure volumes globally. Public health campaigns, media outreach, and advocacy by non-profits have contributed to increased understanding of the importance and safety of living and deceased kidney donation. For instance, in January 2024, a new campaign, "Make Your Mark," was launched to promote living kidney donation and save lives in the UK. The initiative, backed by Kidney Research UK, aimed to raise awareness about the benefits of living kidney donation and encouraged more people to consider donating. With over 7,000 people waiting for a kidney transplant in the UK, the campaign aimed to address the shortage of available kidneys. Such initiatives are expected to increase the kidney donation volumes over the forecast period. Hospitals and transplant centers are responding by adopting more reliable and advanced preservation technologies that ensure efficient organ viability during transport and storage.

The kidney transplant organ preservation is also driven by the rising global prevalence of chronic kidney disease (CKD), Stage Renal Disease (ESRD) and the subsequent increase in demand for kidney transplantation as the preferred treatment option for improved quality of life and survival rates compared to long-term dialysis. According to the American Kidney Fund, an estimated 35.5 million Americans have kidney disease, with about 815,000 living with kidney failure. Nearly 555,000 Americans are undergoing dialysis treatment. Moreover, the prevalence of kidney disease is on the rise, currently affecting more than 1 in 7 (or 14%) of American adults. Similarly, advancements in surgical techniques and immunosuppressive therapies have made transplantation a more viable and successful procedure, encouraging more patients and healthcare systems to choose kidney transplantation.

Technological advancements and increased investment in the development of advanced kidney preservation technologies are also playing a crucial role in driving the kidney transplant organ preservation landscape. In February 2025, the National Kidney Foundation (NKF) Innovation Fund invested in NorthernLight, a medical device company, to advance next-generation kidney preservation technology. This investment aims to improve kidney transplantation outcomes by enhancing preservation techniques. NorthernLight's technology has the potential to increase the availability of transplantation of kidneys. The NKF Innovation Fund supports innovative solutions to improve kidney health and transplantation. Thus, the combination of technology, clinical utility, and financial backing is expected to drive innovation in the market, thereby fueling market growth.

Global Kidney Preservation Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global kidney preservation market report on the basis of preservation solution, technique, donor type, end use, and region:

• Preservation Solution Outlook (Revenue, USD Million, 2021 - 2033)
• University of Wisconsin
• Histidin-Tryptophan-Ketoglutarat (HTK) Solution
• Celsior Solution
• Hypertonic Citrate Adenine (HC-A) Solution
• Institute Georges Lopez (IGL-1) Solution
• Others
• Technique Outlook (Revenue, USD Million, 2021 - 2033)
• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Donor Type Outlook (Revenue, USD Million, 2021 - 2033)
• Standard Criteria Donor (SCD)
• Expanded Criteria Donor (ECD)
• Donation after Brain Death (DBD)
• Donation after Circulatory Death (DCD)
• Living Donor
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Transplant Centers / Hospitals
• Organ Procurement Organizations (OPOs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Preservation solution
  • 1.2.2. Technique
  • 1.2.3. Donor type
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Preservation solutions outlook
  • 2.2.2. Technique outlook
  • 2.2.3. Donor type outlook
  • 2.2.4. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Kidney Preservation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing incidence of kidney-related diseases
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of organ transplantation
    • 3.2.2.2. Significant gap between kidney requirements & availability
• 3.3. Kidney Preservation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Kidney Preservation Market: Preservation Solution Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Kidney Preservation Market: Preservation Solution Movement Analysis
• 4.3. Kidney Preservation Market by Preservation Solution Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. University of Wisconsin
  • 4.5.1. University of Wisconsin Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Histidin-Tryptophan-Ketoglutarat (HTK) Solution
  • 4.6.1. Histidin-Tryptophan-Ketoglutarat (HTK) Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Celsior Solution
  • 4.7.1. Celsior Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Hypertonic Citrate Adenine (HC-A) Solution
  • 4.8.1. Hypertonic Citrate Adenine (HC-A) Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Institute Georges Lopez (IGL-1) Solution
  • 4.9.1. Institute Georges Lopez (IGL-1) Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Kidney Preservation Market: Technique Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Kidney Preservation Market: Technique Movement Analysis
• 5.3. Kidney Preservation Market by Technique Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Static Cold Storage
  • 5.5.1. Static Cold Storage Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Hypothermic Machine Perfusion
  • 5.6.1. Hypothermic Machine Perfusion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Normothermic Machine Perfusion
  • 5.7.1. Normothermic Machine Perfusion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Kidney Preservation Market: Donor Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Kidney Preservation Market: Donor Type Movement Analysis
• 6.3. Kidney Preservation Market by Donor Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Standard Criteria Donor (SCD)
  • 6.5.1. Standard Criteria Donor (SCD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Expanded Criteria Donor (ECD)
  • 6.6.1. Expanded Criteria Donor (ECD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Donation after Brain Death (DBD)
  • 6.7.1. Donation after Brain Death (DBD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Donation after Circulatory Death (DCD)
  • 6.8.1. Donation after Circulatory Death (DCD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Living Donor
  • 6.9.1. Living Donor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Kidney Preservation Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Kidney Preservation Market: End Use Movement Analysis
• 7.3. Kidney Preservation Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Transplant Centers/Hospitals
  • 7.5.1. Transplant Centers/Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Organ Procurement Organizations (OPOs)
  • 7.6.1. Organ Procurement Organizations (OPOs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Kidney Preservation Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Kidney Preservation Market movement analysis
• 8.3. Kidney Preservation Market: Regional Estimates & Trend Analysis by Product, Indication & End Use
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. North America
  • 8.5.1. North America Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. U.S. Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. Canada Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. Mexico Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. UK Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Germany Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement Scenario
    • 8.6.4.5. France Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement Scenario
    • 8.6.5.5. Italy Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement Scenario
    • 8.6.6.5. Spain Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Denmark
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement Scenario
    • 8.6.7.5. Denmark Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Reimbursement Scenario
    • 8.6.8.5. Sweden Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.9. Norway
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Competitive Scenario
    • 8.6.9.3. Regulatory Framework
    • 8.6.9.4. Reimbursement Scenario
    • 8.6.9.5. Norway Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Japan Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. China Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement Scenario
    • 8.6.4.5. India Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement Scenario
    • 8.6.5.5. South Korea Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement Scenario
    • 8.6.6.5. Australia Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement Scenario
    • 8.6.7.5. Thailand Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. Brazil Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Argentina Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement Scenario
    • 8.8.2.5. South Africa Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement Scenario
    • 8.8.3.5. Saudi Arabia Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement Scenario
    • 8.8.4.5. UAE Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement Scenario
    • 8.8.5.5. Kuwait Kidney Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Share Analysis, 2025
• 9.3. Key Company Profiles
  • 9.3.1. TransMedics Inc.
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. XVIVO
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Bridge to Life Ltd.
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Paragonix Technologies Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. OrganOx Limited
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Organ Recovery Systems
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Institut Georges Lopez (IGL)
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Preservation Solutions, Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Dr. Franz Kohler Chemie GmbH
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Essential Pharmaceuticals LLC
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives